SEARCH

SEARCH BY CITATION

References

  • Ali C., Docagne F., Nicole O., et al. (2001) Increased expression of transforming growth factor-beta after cerebral ischemia in the baboon: an endogenous marker of neuronal stress? J. Cereb. Blood Flow Metab. 21, 820827.
  • Aslanyan S., Weir C. J., Diener H. C., Kaste M. and Lees K. R. (2004) Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial. Eur. J. Neurol. 11, 4953.
  • Bailey S. L., Carpentier P. A., McMahon E. J., Begolka W. S. and Miller S. D. (2006) Innate and adaptive immune responses of the central nervous system. Crit. Rev. Immunol. 26, 149188.
  • Bauer S., Muller T. and Hamm S. (2009) Pattern recognition by Toll-like receptors. Adv. Exp. Med. Biol. 653, 1534.
  • Becker K., Kindrick D., Relton J., Harlan J. and Winn R. (2001) Antibody to the alpha4 integrin decreases infarct size in transient focal cerebral ischemia in rats. Stroke 32, 206211.
  • Becker K. J., Kindrick D. L., Lester M. P., Shea C. and Ye Z. C. (2005) Sensitization to brain antigens after stroke is augmented by lipopolysaccharide. J. Cereb. Blood Flow Metab. 25, 16341644.
  • Becker K. J., Kalil A. J., Tanzi P., et al. (2011) Autoimmune Responses to the Brain After Stroke Are Associated With Worse Outcome. Stroke 42, 27632769.
  • Bornstein N. M., Aronovich B., Korczyn A. D., Shavit S., Michaelson D. M. and Chapman J. (2001) Antibodies to brain antigens following stroke. Neurology 56, 529530.
  • Brea D., Blanco M., Ramos-Cabrer P., Moldes O., Arias S., Perez-Mato M., Leira R., Sobrino T. and Castillo J. (2011) Toll-like receptors 2 and 4 in ischemic stroke: outcome and therapeutic values. J. Cereb. Blood Flow Metab. 31, 14241431.
  • Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Torres F. and Planas A. M. (2006) Interleukin 10, monocytes and increased risk of early infection in ischaemic stroke. J. Neurol. Neurosurg. Psychiatry 77, 12791281.
  • Chamorro A., Amaro S., Vargas M., Obach V., Cervera A., Gomez-Choco M., Torres F. and Planas A. M. (2007) Catecholamines, infection, and death in acute ischemic stroke. J. Neurol. Sci. 252, 2935.
  • Chen B., Friedman B., Cheng Q., Tsai P., Schim E., Kleinfeld D. and Lyden P. D. (2009) Severe blood-brain barrier disruption and surrounding tissue injury. Stroke 40, e666674.
  • Czech B., Pfeilschifter W., Mazaheri-Omrani N., Strobel M. A., Kahles T., Neumann-Haefelin T., Rami A., Huwiler A. and Pfeilschifter J. (2009) The immunomodulatory sphingosine 1-phosphate analog FTY720 reduces lesion size and improves neurological outcome in a mouse model of cerebral ischemia. Biochem. Biophys. Res. Commun. 389, 251256.
  • Czlonkowska A., Cyrta B. and Korlak J. (1979) Immunological observations on patients with acute cerebral vascular disease. J. Neurol. Sci. 43, 455464.
  • Dambinova S. A., Khounteev G. A., Izykenova G. A., Zavolokov I. G., Ilyukhina A. Y. and Skoromets A. A. (2003) Blood test detecting autoantibodies to N-methyl-D-aspartate neuroreceptors for evaluation of patients with transient ischemic attack and stroke. Clin. Chem. 49, 17521762.
  • Dangond F., Windhagen A., Groves C. J. and Hafler D. A. (1997) Constitutive expression of costimulatory molecules by human microglia and its relevance to CNS autoimmunity. J. Neuroimmunol. 76, 132138.
  • Denes A., Humphreys N., Lane T. E., Grencis R. and Rothwell N. (2010) Chronic systemic infection exacerbates ischemic brain damage via a CCL5 (regulated on activation, normal T-cell expressed and secreted)-mediated proinflammatory response in mice. J. Neurosci. 30, 1008610095.
  • Felger J. C., Abe T., Kaunzner U. W., Gottfried-Blackmore A., Gal-Toth J., McEwen B. S., Iadecola C. and Bulloch K. (2010) Brain dendritic cells in ischemic stroke: time course, activation state, and origin. Brain Behav. Immun. 24, 724737.
  • Ferrarese C., Mascarucci P., Zoia C., Cavarretta R., Frigo M., Begni B., Sarinella F., Frattola L. and De Simoni M. G. (1999) Increased cytokine release from peripheral blood cells after acute stroke. J. Cereb. Blood Flow Metab. 19, 10041009.
  • Gee J. M., Kalil A., Thullbery M. and Becker K. J. (2008) Induction of immunologic tolerance to myelin basic protein prevents central nervous system autoimmunity and improves outcome after stroke. Stroke 39, 15751582.
  • Gee J. M., Zierath D., Hadwin J., Savos A., Kalil A., Thullbery M. and Becker K. J. (2009) Long term immunologic consequences of experimental stroke and mucosal tolerance. Exp. Transl. Stroke Med. 1, 3.
  • Gottfried-Blackmore A., Kaunzner U. W., Idoyaga J., Felger J. C., McEwen B. S. and Bulloch K. (2009) Acute in vivo exposure to interferon-gamma enables resident brain dendritic cells to become effective antigen presenting cells. Proc. Natl Acad. Sci. USA 106, 2091820923.
  • Grabska K., Gromadzka G. and Czlonkowska A. (2011) Infections and ischemic stroke outcome. Neurol. Res. Int. 2011, 691348.
  • Grau A. J., Urbanek C. and Palm F. (2010) Common infections and the risk of stroke. Nat. Rev. Neurol. 6, 681694.
  • Haeusler K. G., Schmidt W. U., Fohring F., et al. (2008) Cellular immunodepression preceding infectious complications after acute ischemic stroke in humans. Cerebrovasc. Dis. 25, 5058.
  • Haeusler K. G., Schmidt W. U., Foehring F., et al. (2012) Immune responses after acute ischemic stroke or myocardial infarction. Int. J. Cardiol. 155, 372377.
  • Harms H., Reimnitz P., Bohner G., Werich T., Klingebiel R., Meisel C. and Meisel A. (2011) Influence of stroke localization on autonomic activation, immunodepression, and post-stroke infection. Cerebrovasc. Dis. 32, 552560.
  • Hasegawa Y., Suzuki H., Sozen T., Rolland W. and Zhang J. H. (2010) Activation of sphingosine 1-phosphate receptor-1 by FTY720 is neuroprotective after ischemic stroke in rats. Stroke 41, 368374.
  • Herrmann M., Vos P., Wunderlich M. T., de Bruijn C. H. and Lamers K. J. (2000) Release of glial tissue-specific proteins after acute stroke: a comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein. Stroke 31, 26702677.
  • Hong K. S., Kang D. W., Koo J. S., Yu K. H., Han M. K., Cho Y. J., Park J. M., Bae H. J. and Lee B. C. (2008) Impact of neurological and medical complications on 3-month outcomes in acute ischaemic stroke. Eur. J. Neurol. 15, 13241331.
  • Hug A., Dalpke A., Wieczorek N., Giese T., Lorenz A., Auffarth G., Liesz A. and Veltkamp R. (2009) Infarct volume is a major determiner of post-stroke immune cell function and susceptibility to infection. Stroke 40, 32263232.
  • Hug A., Liesz A., Muerle B., Zhou W., Ehrenheim J., Lorenz A., Dalpke A. and Veltkamp R. (2011) Reduced efficacy of circulating costimulatory cells after focal cerebral ischemia. Stroke 42, 35803586.
  • Intiso D., Zarrelli M. M., Lagioia G., Di Rienzo F., Checchia De Ambrosio C., Simone P., Tonali P. and Cioffi Dagger R. P. (2004) Tumor necrosis factor alpha serum levels and inflammatory response in acute ischemic stroke patients. Neurol. Sci. 24, 390396.
  • Jander S., Kraemer M., Schroeter M., Witte O. W. and Stoll G. (1995) Lymphocytic infiltration and expression of intercellular adhesion molecule-1 in photochemically induced ischemia of the rat cortex. J. Cereb. Blood Flow Metab. 15, 4251.
  • Jauch E. C., Lindsell C., Broderick J., Fagan S. C., Tilley B. C. and Levine S. R. (2006) Association of serial biochemical markers with acute ischemic stroke: the National Institute of Neurological Disorders and Stroke recombinant tissue plasminogen activator Stroke Study. Stroke 37, 25082513.
  • Kallen B., Nilsson O. and Thelin C. (1977) Effect of encephalitogenic protein on migration in agarose of leukoytes from patients with multiple sclerosis. A longitudinal study of patients with relapsing multiple sclerosis or with cerebral infarction. Acta Neurol. Scand. 55, 4756.
  • Klehmet J., Harms H., Richter M., Prass K., Volk H. D., Dirnagl U., Meisel A. and Meisel C. (2009) Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 158, 11841193.
  • Krupinski J., Kumar P., Kumar S. and Kaluza J. (1996) Increased expression of TGF-beta 1 in brain tissue after ischemic stroke in humans. Stroke 27, 852857.
  • Liesz A., Hagmann S., Zschoche C., et al. (2009a) The spectrum of systemic immune alterations after murine focal ischemia: immunodepression versus immunomodulation. Stroke 40, 28492858.
  • Liesz A., Suri-Payer E., Veltkamp C., Doerr H., Sommer C., Rivest S., Giese T. and Veltkamp R. (2009b) Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat. Med. 15, 192199.
  • Liesz A., Sun L., Zhou W., Schwarting S., Mracsko E., Zorn M., Bauer H., Sommer C. and Veltkamp R. (2011a) FTY720 reduces post-ischemic brain lymphocyte influx but does not improve outcome in permanent murine cerebral ischemia. PLoS ONE 6, e21312.
  • Liesz A., Zhou W., Mracsko E., et al. (2011b) Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 134, 704720.
  • Mannie M., Swanborg R. H. and Stepaniak J. A. (2009) Experimental autoimmune encephalomyelitis in the rat. Curr. Protoc. Immunol. (Suppl. 85), 15.2.115.2.15 Chapter 15, Unit 15.2.
  • Mazzotta G., Sarchielli P., Caso V., Paciaroni M., Floridi A., Floridi A. and Gallai V. (2004) Different cytokine levels in thrombolysis patients as predictors for clinical outcome. Eur. J. Neurol. 11, 377381.
  • Meisel C., Prass K., Braun J., et al. (2004) Preventive antibacterial treatment improves the general medical and neurological outcome in a mouse model of stroke. Stroke 35, 26.
  • Montaner J., Rovira A., Molina C. A., Arenillas J. F., Ribo M., Chacon P., Monasterio J. and Alvarez-Sabin J. (2003) Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke. J. Cereb. Blood Flow Metab. 23, 14031407.
  • Offner H., Subramanian S., Parker S. M., Afentoulis M. E., Vandenbark A. A. and Hurn P. D. (2006) Experimental stroke induces massive, rapid activation of the peripheral immune system. J. Cereb. Blood Flow Metab. 26, 654665.
  • Olson J. K. and Miller S. D. (2004) Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 173, 39163924.
  • Planas A. M., Gomez-Choco M., Urra X., Gorina R., Caballero M. and Chamorro A. (2012) Brain-derived antigens in lymphoid tissue of patients with acute stroke. J. Immunol. 188, 21562163.
  • Prass K., Meisel C., Hoflich C., et al. (2003) Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J. Exp. Med. 198, 725736.
  • Raymond C. R. and Wilkie B. N. (2005) Toll-like receptor, MHC II, B7 and cytokine expression by porcine monocytes and monocyte-derived dendritic cells in response to microbial pathogen-associated molecular patterns. Vet. Immunol. Immunopathol. 107, 235247.
  • Relton J. K., Sloan K. E., Frew E. M., Whalley E. T., Adams S. P. and Lobb R. R. (2001) Inhibition of alpha4 integrin protects against transient focal cerebral ischemia in normotensive and hypertensive rats. Stroke 32, 199205.
  • Ren X., Akiyoshi K., Vandenbark A. A., Hurn P. D. and Offner H. (2011) CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke. Metab. Brain Dis. 26, 8790.
  • Rogers S. L., Coe C. L. and Karaszewski J. W. (1998) Immune consequences of stroke and cerebral palsy in adults. J. Neuroimmunol. 91, 113120.
  • Romo-Gonzalez T., Chavarria A. and Perez H. J. (2012) Central nervous system: a modified immune surveillance circuit?. Brain Behav. Immun. 26, 823829.
  • Schroeter M., Jander S., Witte O. W. and Stoll G. (1994) Local immune responses in the rat cerebral cortex after middle cerebral artery occlusion. J. Neuroimmunol. 55, 195203.
  • Schulte-Herbruggen O., Klehmet J., Quarcoo D., Meisel C. and Meisel A. (2006) Mouse strains differ in their susceptibility to poststroke infections. NeuroImmunoModulation 13, 1318.
  • Sfriso P., Ghirardello A., Botsios C., Tonon M., Zen M., Bassi N., Bassetto F. and Doria A. (2010) Infections and autoimmunity: the multifaceted relationship. J. Leukoc. Biol. 87, 385395.
  • Sotgiu S., Zanda B., Marchetti B., et al. (2006) Inflammatory biomarkers in blood of patients with acute brain ischemia. Eur. J. Neurol. 13, 505513.
  • Suter T., Biollaz G., Gatto D., Bernasconi L., Herren T., Reith W. and Fontana A. (2003) The brain as an immune privileged site: dendritic cells of the central nervous system inhibit T cell activation. Eur. J. Immunol. 33, 29983006.
  • Tamayo E., Fernandez A., Almansa R., et al. (2011) Pro- and anti-inflammatory responses are regulated simultaneously from the first moments of septic shock. Eur. Cytokine Netw. 22, 8287.
  • Tanzi P., Cain K., Kalil A., et al. (2011) Post-stroke infection: a role for IL-1ra? Neurocrit. Care 14, 244252.
  • Tuttolomondo A., Di Sciacca R., Di Raimondo D., et al. (2009) Plasma levels of inflammatory and thrombotic/fibrinolytic markers in acute ischemic strokes: relationship with TOAST subtype, outcome and infarct site. J. Neuroimmunol. 215, 8489.
  • Urra X., Cervera A., Obach V., Climent N., Planas A. M. and Chamorro A. (2009a) Monocytes are major players in the prognosis and risk of infection after acute stroke. Stroke 40, 12621268.
  • Urra X., Cervera A., Villamor N., Planas A. M. and Chamorro A. (2009b) Harms and benefits of lymphocyte subpopulations in patients with acute stroke. Neuroscience 158, 11741183.
  • Urra X., Villamor N., Amaro S., Gomez-Choco M., Obach V., Oleaga L., Planas A. M. and Chamorro A. (2009c) Monocyte subtypes predict clinical course and prognosis in human stroke. J. Cereb Blood Flow Metab 29, 9941002.
  • Vermeij F. H., Scholte op Reimer W. J., de Man P., van Oostenbrugge R. J., Franke C. L., de Jong G., de Kort P. L. and Dippel D. W. (2009) Stroke-associated infection is an independent risk factor for poor outcome after acute ischemic stroke: data from the Netherlands Stroke Survey. Cerebrovasc. Dis.. 27, 465471.
  • Vogelgesang A., Grunwald U., Langner S., Jack R., Broker B. M., Kessler C. and Dressel A. (2008) Analysis of lymphocyte subsets in patients with stroke and their influence on infection after stroke. Stroke 39, 237241.
  • Vogelgesang A., May V. E., Grunwald U., Bakkeboe M., Langner S., Wallaschofski H., Kessler C., Broker B. M. and Dressel A. (2010) Functional status of peripheral blood T-cells in ischemic stroke patients. PLoS ONE 5, e8718.
  • Wang W. Z., Olsson T., Kostulas V., Hojeberg B., Ekre H. P. and Link H. (1992) Myelin antigen reactive T cells in cerebrovascular diseases. Clin. Exp. Immunol. 88, 157162.
  • Wei Y., Yemisci M., Kim H. H., et al. (2011) Fingolimod provides long-term protection in rodent models of cerebral ischemia. Ann. Neurol. 69, 119129.
  • de Werra I., Jaccard C., Corradin S. B., et al. (1997) Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit. Care Med. 25, 607613.
  • Westendorp W. F., Nederkoorn P. J., Vermeij J. D., Dijkgraaf M. G. and van de Beek D. (2011) Post-stroke infection: a systematic review and meta-analysis. BMC Neurol. 11, 110.
  • Wong C. H., Jenne C. N., Lee W. Y., Leger C. and Kubes P. (2011) Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 334, 101105.
  • Yan J., Read S. J., Henderson R. D., Hull R., O'Sullivan J. D., McCombe P. A. and Greer J. M. (2012) Frequency and function of regulatory T cells after ischaemic stroke in humans. J. Neuroimmunol. 243, 8994.
  • Yang Q. W., Li J. C., Lu F. L., Wen A. Q., Xiang J., Zhang L. L., Huang Z. Y. and Wang J. Z. (2008) Upregulated expression of toll-like receptor 4 in monocytes correlates with severity of acute cerebral infarction. J. Cereb. Blood Flow Metab. 28, 15881596.
  • Youngchaiyud U., Coates A. S., Whittingham S. and Mackay I. R. (1974) Cellular-immune response to myelin protein: absence in multiple sclerosis and presence in cerebrovascular accidents. Aust. N. Z. J. Med. 4, 535538.
  • Zaremba J. and Losy J. (2001) Early TNF-alpha levels correlate with ischaemic stroke severity. Acta Neurol. Scand. 104, 288295.
  • Zhang D. P., Yan F. L., Xu H. Q., Zhu Y. X., Yin Y. and Lu H. Q. (2009) A decrease of human leucocyte antigen-DR expression on monocytes in peripheral blood predicts stroke-associated infection in critically-ill patients with acute stroke. Eur. J. Neurol. 16, 498505.
  • Zierath D., Thullbery M., Hadwin J., Gee J. M., Savos A., Kalil A. and Becker K. J. (2010) CNS immune responses following experimental stroke. Neurocrit Care 12, 274284.
  • van Zwam M., Huizinga R., Melief M. J., et al. (2009) Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE. J. Mol. Med. 87, 273286.
  • Zygmunt B. and Veldhoen M. (2011) T helper cell differentiation more than just cytokines. Adv. Immunol. 109, 159196.